Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3NET 1Endocrine 1

Conditions

Breast Neoplasms 2Inflammatory Breast Neoplasms 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × 89Zr-bevacizumab × Breast × Clear all
NCT01894451 2019-12-12

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
2 enrolled
Breast

Inflammatory Breast Neoplasms

NCT01081613 2012-09-06

Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)

University Medical Center Groningen

Completed
7 enrolled
Breast

Breast Neoplasms

NCT00991978 2012-03-30

VEGF Early Imaging for Breast Cancer

University Medical Center Groningen

Phase EARLY_PHASE1 Completed
23 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡